TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Merck Life Science A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,398,642
|
1,256,087
|
1,008,596 |
| Earnings before taxes |
94,653
|
58,240
|
51,417 |
| Total assets |
322,677
|
233,186
|
249,887 |
| Current assets |
321,113
|
230,058
|
245,196 |
| Current liabilities |
82,634
|
66,248
|
34,164 |
| Equity capital |
239,855
|
166,245
|
214,691 |
| - share capital |
2,001
|
2,001
|
2,001 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.3%
|
71.3%
|
85.9% |
| Turnover per employee |
199,806
|
179,441
|
144,085 |
| Profit as a percentage of turnover |
6.8%
|
4.6%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
388.6%
|
347.3%
|
717.7% |
| Return on equity (ROE) |
39.5%
|
35.0%
|
23.9% |
| Change turnover |
142,555
|
247,491
|
240,403 |
| Change turnover % |
11%
|
25%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.